A research team has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration and that targeting specific retinal cell types may lead to treatments ...

Dr. Amy Peot with Shopko Optical joined the Living with Amy show to talk about how getting enough rest leads to healthy eye ...

Research team awarded five-year, $3.2 million grant from National Institute on Deafness and Other Communication DisordersWith ...

Tebentafusp is the first treatment of its kind for uveal melanoma, which develops from cells in the middle layer of the eye, ...

A team of Bascom Palmer Eye Institute and University of Miami researchers have received an award to fund the procurement, ...

Discover more about identifying and selecting the most relevant in vitro models for accurately predicting human renal ...

Cost-effectiveness agency NICE has recommended NHS use of the therapy, called Kimmtrak (tebentafusp), for the treatment of ...

Officials have announced people with a rare form of eye cancer will have access to a "pioneering" drug on the NHS which could ...

The National Audit Office (NAO) said current expansion plans are “insufficient to meet future demand” amid a projected ...

Eye stroke' is a disease that causes the central arteries of the retina to block and cause rapid vision loss, leading to ...

Tebentafusp - sold under the brand name Kimmtrak - is the first treatment of its kind for uveal melanoma, which develops from ...

The pioneering new drug was found to increase average overall survival by almost five months compared to other standard ...